Related references
Note: Only part of the references are listed.Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma
Wael Naboulsi et al.
JOURNAL OF PROTEOME RESEARCH (2016)
Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology
Christian A. Gleissner et al.
ATHEROSCLEROSIS (2016)
Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
Yonghai Lu et al.
CANCER RESEARCH (2016)
Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma
Hussein Abou-Abbass et al.
ELECTROPHORESIS (2016)
Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma
Wei Sun et al.
SCIENTIFIC REPORTS (2016)
Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases
Dan Zhang et al.
SCIENTIFIC REPORTS (2016)
An effective and in-situ method based tresyl-functionalized porous polymer material for enrichment and digestion of membrane proteins and its application in extraction tips
Jiaxi Wang et al.
ANALYTICA CHIMICA ACTA (2015)
Displacement Phenomena in Lectin Affinity Chromatography
Wonryeon Cho
ANALYTICAL CHEMISTRY (2015)
Loss of α1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways
Yuqin Wang et al.
FASEB JOURNAL (2015)
Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index
Shu Zhang et al.
GLYCOCONJUGATE JOURNAL (2015)
Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma
Haidi Yin et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Galectin-3 Binding Protein and Galectin-1 Interaction in Breast Cancer Cell Aggregation and Metastasis
Tzu-Wen Lin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Integrated Proteomic and miRNA Transcriptional Analysis Reveals the Hepatotoxicity Mechanism of PFNA Exposure in Mice
Jianshe Wang et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis
Shilpa A. Patil et al.
GLYCOCONJUGATE JOURNAL (2014)
Altered N-Glycan Expression Profile in Epithelial-to-Mesenchymal Transition of NMuMG Cells Revealed by an Integrated Strategy Using Mass Spectrometry and Glycogene and Lectin Microarray Analysis
Zengqi Tan et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE
Gustavo Ferrin et al.
LIVER INTERNATIONAL (2014)
Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MS
Yangguang Li et al.
MOLECULAR BIOSYSTEMS (2013)
Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients
Chun Sun et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Cloning and characterization of a viral α2-3-sialyltransferase (vST3Gal-I) for the synthesis of sialyl Lewisx
Go Sugiarto et al.
GLYCOBIOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
Peng Qi et al.
PLOS ONE (2011)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
Combining Results from Lectin Affinity Chromatography and Glycocapture Approaches Substantially Improves the Coverage of the Glycoproteome
Claudia A. McDonald et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Altered glycosylation of proteins in cancer: What is the potential for new anti-tumour strategies
S. A. Brooks et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease
Noah T. Zinkin et al.
CLINICAL CANCER RESEARCH (2008)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Mechanisms of crosstalk between TNF-induced NF-κB and JNK activation in hepatocytes
Andy Wullaert et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers
Richard R. Drake et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Heat-shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis
JT Feng et al.
PROTEOMICS (2005)
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
E Schiffer et al.
HEPATOLOGY (2005)
α-2-macroglobulin:: A novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers
T Sukata et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
The human plasma proteome - History, character, and diagnostic prospects
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
D Liu et al.
CANCER CELL (2002)
Share Paper
